Chlamydophila pneumoniae inhibits differentiation of progenitor adipose cells and impairs insulin signaling

Journal of Infectious Diseases

Volumn 197, Issue 3, 2008, Pages 439-448

  Shi, Yu ^a   Liu, Youan ^a   Murdin, Andrew ^b   Raudonikiene Mancevski, Ausra ^b   Ayach, Bilal B ^a,d   Yu, Zhiwen ^c   Fantus, I George ^a,c,d   Liu, Peter P ^a,d,e  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Sanofi Pasteur   (Canada)

^c Banting and Best Diabetes Centre   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 65; INSULIN; INSULIN RECEPTOR; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TYROSINE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIUM DETECTION; CELL DIFFERENTIATION; CELL ISOLATION; CELL STRAIN 3T3; CHLAMYDOPHILA PNEUMONIAE; DOWN REGULATION; EPIDIDYMIS FAT; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN PHOSPHORYLATION; STEM CELL; WILD TYPE;

3T3 CELLS; ADIPOSE TISSUE; ANIMALS; ANNEXIN A5; CELL DIFFERENTIATION; CHLAMYDOPHILA PNEUMONIAE; HELA CELLS; HUMANS; INSULIN; KINETICS; MICE; SIGNAL TRANSDUCTION;

EID: 39349117675     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/525045     Document Type: Article

References (46)

1. Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2003; 52:1799-805.
2. Kahn BB, JS Flier. Obesity and insulin resistance. J Clin Invest 2000; 106:473-81.
3. Rajala MW, PE Scherer. Minireview: the adipocyte - at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003; 144:3765-73.
4. Hotamisligil GS. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999; 245:621-5.
5. Hotamisligil GS, NS Shargill, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259:87-91.
6. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95:2111-9.
7. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95:2409-15.
8. Leinonen M. Chlamydia pneumoniae and other risk factors for atherosclerosis. J Infect Dis 2000; 181(Suppl 3):S414-6.
9. Fernandez-Real JM, Lopez-Bermejo A, Vendrell J, Ferri MJ, Recasens M, Ricart W. Burden of infection and insulin resistance in healthy middleaged men. Diabetes Care 2006; 29:1058-64.
10. Whigham LD, Israel BA, Atkinson RL. Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am J Physiol Regul Integr Comp Physiol 2006; 290:R190-4.
11. Todaro GJ, H Green. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 1963; 17:299-313.
12. Green H, Kehinde O. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 1976; 7:105-13.
13. Hotamisligil GS, Peraldi P, Budavari A, et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996; 271:665-8.
14. Scherer PE, Williams S, Fogliano M, Baldinin G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270:26746-9.
15. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 1997; 100:2777-82.
16. Wellen KE, GS Hotamisligil. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112:1785-8.
17. Belland RJ, Oeullette SP, Gieffers J Byrne GI. Chlamydia pneumoniae and atherosclerosis. Cell Microbiol 2004; 6:117-27.
18. Aratani Y, Y Kitagawa. Enhanced synthesis and secretion of type IV collagen and entactin during adipose conversion of 3T3-L1 cells and production of unorthodox laminin complex. J Biol Chem 1988; 263:16163-9.
19. Ramirez-Zacarias JL, Castro-Munozledo F, Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O. Histochemistry 1992; 97:493-7.
20. Murdin AD, Dunn P, Sodoyer R, et al. Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection. J Infect Dis 2000; 181 (Suppl 3):S544-51.
21. Ajuwon KM, Jacobi SK, Kuske JL, Spurlock ME. Interleukin-6 and interleukin-15 are selectively regulated by lipopolysaccharide and interferon-gamma in primary pig adipocytes. Am J Physiol Regul Integr Comp Physiol 2004; 286:R547-53.
22. Molestina RE, Miller RD, Ramirez JA, Summersgill JT. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect Immun 1999; 67:1323-30.
23. Hogan RJ, Mathews SA, Kutlin A, Hammerschlag MR, Timms P. Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections. Microb Pathog 2003; 34:11-6.
24. Wang G, Burczynski F, Hasinoff B, Zhong G. Infection of myocytes with chlamydiae. Microbiology 2002; 148:3955-9.
25. Fuse K, Chan G, Liu Y, et al. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation 2005; 112:2276-85.
26. Byrne GI, Ojcius DM. Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2004; 2:802-8.
27. Szalkowski D, White-Carrington S, Berger J, Zhang B. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 1995; 136:1474-81.
28. Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, Sherer PE. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem 2000; 275:24255- 63.
29. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factoralpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003; 278:45777-84.
30. Ruan H, Zarnoski MJ, Cushman SW, Lodish HF. Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes. J Biol Chem 2003; 278:47585-93.
31. Barnes PJ. Corticosteroid effects on cell signalling. Eur Respir J 2006; 27:413-26.
32. Darville T, Andrews CW Jr, Laffoon KK, Shymasani W, Kishen LR, Rank RG. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect Immun 1997; 65:3065-73.
33. Spiegelman BM. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 1998; 47:507-14.
34. Godzik KL, O'Brien ER, Wang SK, Kuo CC. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 1995; 33:2411-4.
35. Sriram S, Ljunggren-Rose A, Yao SY, Whetsell WO Jr. Detection of chlamydial bodies and antigens in the central nervous system of patients with multiple sclerosis. J Infect Dis 2005; 192:1219-28.
36. Ardeniz O, Gülbahar O, Mete N, et al. Chlamydia pneumoniae arthritis in a patient with common variable immunodeficiency. Ann Allergy Asthma Immunol 2005; 94:504-8.
37. Geng Y, Shane RB, Berencsi K, et al. Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. J Immunol 2000; 164:5522-9.
38. Stenner-Liewen F, Liewen H, Zapata JM, Pawlowski K, Godzik A, Reed JC. CADD, a Chlamydia protein that interacts with death receptors. J Biol Chem 2002; 277:9633-6.
39. Kol A, Sukhova GK, Lichman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998; 98:300-7.
40. Redecke V, Dalhoff K, Bohnet S, Braun J Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol 1998; 19:721-7.
41. Young KD, Anderson RJ, Hafner RJ. Lysis of Escherichia coli by the bacteriophage phi X174 E protein: inhibition of lysis by heat shock proteins. J Bacteriol 1989; 171:4334-41.
42. Haranaga S, Yamaguchi H, Ikejima H, Friedman H, Yamamoto Y. Chlamydia pneumoniae infection of alveolar macrophages: a model. J Infect Dis 2003; 187:1107-15.
43. Cho YS, Kim TB, Lee TH, et al. Chlamydia pneumoniae infection enhances cellular proliferation and reduces steroid responsiveness of human peripheral blood mononuclear cells via a tumor necrosis factor-alpha-dependent pathway. Clin Exp Allergy 2005; 35:1625-31.
44. Xu H, GS Hotamisligil. Signaling pathways utilized by tumor necrosis factor receptor 1 in adipocytes to suppress differentiation. FEBS Lett 2001; 506:97-102.
45. Zhang B, Berger J, Ju E, et al. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol Endocrinol 1996; 10:1457-66.
46. Xing H, Northrop JP, Grove JR, Kilpatrick KE, Su JL, Ringold GM. TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARgamma without effects on Pref-1 expression. Endocrinology 1997; 138:2776-83.